A German research team’s discoveries about autoimmune diseases are opening up new possibilities for patients with lupus and ...

Instead, we're recruiting healthy soldiers from disease-free, well donors and equipping them with special targeting systems ...

Autoimmune diseases, in which the immune system mistakenly attacks the body's own healthy cells and tissues, often include a ...

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that's characterized by mild symptoms or ...

Now, scientists at Stanford University have found that a faulty genetic molecule could be responsible for the immune system misidentifying healthy tissue as a threat. The breakthrough study, published ...

Descartes-15 is under clinical development by Cartesian Therapeutics and currently in Phase I for Autoimmune Disorders.

AKP-11 is under clinical development by Akaal Pharma and currently in Phase I for Autoimmune Disorders. According to GlobalData, Phase I drugs for Autoimmune Disorders have a 73% phase transition ...

PD-1 x VEGF antibodies show potential to surpass checkpoint inhibitors as standard-of-care in multiple oncology indications • NAYA aiming to initiate clinical trials in earl ...

The scarring that occurs with cirrhosis is usually irreversible, but treatment can help manage ... family history of autoimmune diseases, or other risk factors. If your blood is unable to pass ...